Hemab Therapeutics (COAG) Fair Value & DCF

COAG$40.48+1.10 +2.79%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$1.89BEnterprise value$1.39BRevenue (TTM)$0Market position—

Score

70
Bullish
Value
66
Quality
50
Growth
95

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) trades at $40.48 on $1.89B of equity value, with a trailing P/E of -26.58. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Hemab Therapeutics (COAG) Fair Value & DCF

COAG price $40.48 +1.10 +2.79%

Ticker
COAG
Price
$40.48
Change
+1.10 +2.79%
Market cap
$1.89B
Dividend yield
0.00%
Beta
1.85
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
66
Quality
50
Growth
95

Stocklytics score rationale: value 66, quality 50, growth 95.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener